Diagnosis of endocrinological hypertension: When to screen, and by which method?;Diagnostik einer endokrinen Hypertonie: Wann screenen, und mit welchem Test?

Deutsche Medizinische Wochenschrift

Volumn 136, Issue 11, 2011, Pages 537-540

  Fischer, E ^a   Beuschlein, F ^a   Reincke, M ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

hypertension

Indexed keywords

ARTICLE; ENDOCRINOLOGICAL HYPERTENSION; HYPERTENSION; SCREENING;

ADRENAL GLAND DISEASES; ADRENAL GLAND NEOPLASMS; CUSHING SYNDROME; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; MASS SCREENING; PHEOCHROMOCYTOMA;

EID: 79952501772     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0031-1274538     Document Type: Article

References (20)

1. Baguet J P. et al,. Circumstances of discovery of phaeochromocytoma: a retrospective study of 41 consecutive patients. Eur J Endocrinol 2004 150 681-686
2. Beuschlein F, Reincke M. [Therapy-resistant hypertension - the endocrinological view]. MMW Fortschr Med 2007 149 29-32
3. Born-Frontsberg E, Quinkler M. [Conn's syndrome]. Internist 2009 50 17-26
4. Dodt C et al,. [Glucocorticoids and hypertension]. Internist 2009 50 36-41
5. Findling J W., Raff H. Screening and diagnosis of Cushing's syndrome. Endocrinol Metab Clin North Am 2005 34 385-402 (Pubitemid 40602728)
6. Funder J W. et al,. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2008 93 3266-3281
7. Hannemann A. The increased aldosterone-to-renin ratio in North and South Germany: Results from SHIP and KORA. Dtsch Med Wochenschr 2010 135 Suppl. 4 148 (Abstract)
8. Karagiannis A et al,. Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism. Expert Opin Pharmacother 2008 9 509-515 (Pubitemid 351425379)
9. Kearney P M. et al,. Global burden of hypertension: analysis of worldwide data. Lancet 2005 365 217-223 (Pubitemid 40138015)
10. Lenders J W. et al,. Biochemical diagnosis of pheochromocytoma: which test is best? J Am Med Assoc 2002 287 1427-1434 (Pubitemid 34250506)
11. Mulatero P et al,. Evaluation of primary aldosteronism. Curr Opin Endocrinol Diabetes Obes 2010 17 188-193
12. Nieman L K. et al,. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2008 93 1526-1540 (Pubitemid 351656485)
13. Reisch N et al,. [Pheochromocytoma - still a challenge]. Internist 2009 50 27-35
14. Rossi G P. et al,. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 2006 48 2293-300 (Pubitemid 44873058)
15. Rossi G P., Seccia T M., Pessina A C. Clinical use of laboratory tests for the identification of secondary forms of arterial hypertension. Crit Rev Clin Lab Sci 2007 44 1-85 (Pubitemid 44973616)
16. Tomaschitz A, Pilz S. Aldosterone to renin ratio - a reliable screening tool for primary aldosteronism? Horm Metab Res 2010 42 382-391
17. Viardot A et al,. Reproducibility of nighttime salivary cortisol and its use in the diagnosis of hypercortisolism compared with urinary free cortisol and overnight dexamethasone suppression test. J Clin Endocrinol Metab 2005 90 5730-5736 (Pubitemid 41415483)
18. Yeo H, Roman S. Pheochromocytoma and functional paraganglioma. Curr Opin Oncol 2005 17 13-18 (Pubitemid 40179905)
19. Young W F. Primary aldosteronism: renaissance of a syndrome. Clin Endocrinol (Oxf) 2007 66 607-618 (Pubitemid 46699525)
20. Montori V M., Young jr W F. Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism. Endocrinol Metab Clin North Am 2002 31 619-632 (Pubitemid 35006613)